1-(2-{(Z)-2-[4-Fluoro-2-(4-fluorobenzyl)phenyl]vinyloxy}ethyl)nipecotic acid

ID: ALA2387669

PubChem CID: 71660390

Max Phase: Preclinical

Molecular Formula: C23H25F2NO3

Molecular Weight: 401.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)C1CCCN(CCO/C=C\c2ccc(F)cc2Cc2ccc(F)cc2)C1

Standard InChI:  InChI=1S/C23H25F2NO3/c24-21-6-3-17(4-7-21)14-20-15-22(25)8-5-18(20)9-12-29-13-11-26-10-1-2-19(16-26)23(27)28/h3-9,12,15,19H,1-2,10-11,13-14,16H2,(H,27,28)/b12-9-

Standard InChI Key:  CKGRYFOTNXJPRK-XFXZXTDPSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   37.4352   -2.3335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0266   -3.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4352   -3.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0266   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2094   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8008   -3.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2094   -3.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0266   -1.6244    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.2524   -2.3335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.9836   -3.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5750   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7578   -4.4566    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3492   -5.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5320   -5.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1234   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3063   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8977   -3.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3063   -3.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1234   -3.0384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5320   -3.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8977   -5.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0805   -5.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6719   -5.8707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8547   -5.8707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4461   -5.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8547   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6719   -4.4566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6289   -5.1657    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.8977   -2.3335    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  2  7  1  0
  1  8  2  0
  1  9  1  0
 10 11  1  0
 13 14  2  0
 12 13  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 22 27  2  0
 25 28  1  0
 16 21  1  0
 18 29  1  0
 14 15  1  0
 11 12  1  0
  6 10  1  0
M  END

Associated Targets(non-human)

Slc6a13 GABA transporter 3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a11 GABA transporter 4 (930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a1 GABA transporter 1 (1980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 401.45Molecular Weight (Monoisotopic): 401.1803AlogP: 4.34#Rotatable Bonds: 8
Polar Surface Area: 49.77Molecular Species: ZWITTERIONHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.58CX Basic pKa: 9.34CX LogP: 2.13CX LogD: 2.12
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -0.43

References

1. Quandt G, Höfner G, Wanner KT..  (2013)  Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.,  21  (11): [PMID:23598250] [10.1016/j.bmc.2013.02.056]

Source